Fund strategy
The Portfolio's investment objective is growth of capital. In seeking to achieve this investment objective, the Investment Manager expects that at any time at least 80% of the Portfolio's total assets will be invested in securities issued by companies principally engaged in health care and health care-related industries (Health Care Industries) and in no case will the amount of the Portfolio's total assets invested in such securities be less than two-thirds of the Portfolio's total assets.
Performance
Fees and Expenses
Total Returns
Fund's details
Geographical Distribution
Fund's portfolio distribution among the different geographical areas.
| United States of America | 62,27% | |
| Denmark | 11,43% | |
| Switzerland | 9,89% | |
| Japan | 5,88% | |
| United Kingdom | 4,66% | |
| Australia | 2,27% | |
| France | 1,46% | |
| Ireland | 0,93% | |
| Germany | 0,71% | |
| Others | 0,50% |
By investments
Fund's investments distribution.
| Unitedhealth Group | 9,75% |
| Roche Holdings | 6,72% |
| Novo Nordisk A/s | 6,53% |
| Amgen | 6,39% |
| Anthem Inc | 5,65% |
| Vertex Pharmaceuticals | 5,12% |
| Gsk Plc | 4,49% |
| Pfizer | 4,16% |
| Regeneron Pharmaceuticals | 3,56% |
| Zoetis Inc | 2,87% |
By sector
Fund's possitions distribution by the sdctor they belong to.
| Pharmaceuticals | 31,12% |
| Biotechnology | 19,56% |
| Health Care Providers & Services | 18,95% |
| Health Care Equipment & Supplies | 13,38% |
| Life Sciences Tools & Services | 7,89% |
| Cash & Others | 3,82% |
| Health Care Technology | 2,41% |
| It Services | 2,09% |
| Personal Goods | 0,78% |
Health
